Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shancigu is a traditional Chinese medicinal herb derived from the pseudobulb of plants in the genus Cremastra (notably Cremastra appendiculata) and sometimes Pleione or Iphigenia species. It is classified as an herb that clears heat and resolves toxicity. Traditionally, it has been used to treat toxic lesions such as sores, abscesses, carbuncles, scrofula (lymph node tuberculosis), phlegm nodules, abdominal masses including tumors (especially adenocarcinoma), inflammation-related conditions like urticaria and malignant sores, as well as snake and dog bites. The main active chemical constituents include organic acids, glycosides, phenanthrenes (such as colchicine), and bibenzyl compounds[2][4]. Colchicine is known for its high toxicity; therefore shancigu should be used with caution due to potential adverse effects[4]. The herb can be administered internally or topically but should not be consumed in large doses or over long periods due to its toxicity[5]. There are two commercial specifications of shancigu—"Maocigu" and "Bingqiuzi"—which differ in appearance and chemical composition[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shancigu.